Physician

James R Beattie, MD

According to 2025 Medicare claims, James Beattie, MD (NPI: 1922037704) practices cardiology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is PRINCETON INTERVENTIONAL CARDIOLOGY PA (NPI: 1154353902; TIN: 223258770) and primary practice location at 08540-1968. Beattie is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Beattie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,176 traditional Medicare patients, billed 6,134 HCPCS/CPT codes, and received $379,176 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,788 prescription claims across 815 beneficiaries totaling $1,264,688 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 12 claims. Open Payments data shows 3 records totaling $47. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $537,223 to $1,264,688. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,399 to $642.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,764	8,179	$486,043
2016	2,376	6,988	$426,383
2017	2,000	5,813	$415,627
2018	1,975	6,140	$419,971
2019	2,044	6,008	$388,627
2020	1,886	5,368	$345,905
2021	2,347	6,049	$389,583
2022	2,249	6,072	$411,735
2023	2,416	6,351	$382,408
2024	2,176	6,134	$379,176

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	504	5,391	$537,223
2016	516	5,277	$617,834
2017	524	5,326	$695,363
2018	569	5,332	$756,749
2019	587	5,621	$887,242
2020	610	5,448	$903,749
2021	620	5,800	$1,075,536
2022	671	5,962	$1,089,341
2023	734	6,292	$1,173,792
2024	815	6,788	$1,264,688

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	143	$58,005
2016	N/R	92	$77,025
2017	N/R	N/R	N/R
2018	N/R	26	$793
2019	N/R	N/R	N/R
2020	N/R	12	$307
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	778	812	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	300	452	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	445	618	$64
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	603	1,047	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	954	1,205	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	430	30,046	$570,116
Xarelto	Rivaroxaban	189	13,851	$250,908
Entresto	Sacubitril/Valsartan	43	3,544	$74,448
Jardiance	Empagliflozin	33	2,712	$50,412
Praluent Pen	Alirocumab	49	3,052	$49,641

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$47	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James R. Beattie, MD?

Tedicare shows public-source Medicare data for James R. Beattie, MD (NPI 1922037704), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James R. Beattie, MD have ACO affiliation data?

James R. Beattie, MD is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to James R. Beattie, MD?

James R. Beattie, MD is linked to PRINCETON INTERVENTIONAL CARDIOLOGY PA (billing NPI 1154353902) in the available physician profile data.

Does James R. Beattie, MD have Open Payments data?

James R. Beattie, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.